Bialecki Andrew 4
4 · Klaviyo, Inc. · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
Klaviyo (KVYO) CEO Andrew Bialecki Sells 200,000 Shares
What Happened Andrew P. Bialecki, CEO of Klaviyo, converted Series B common shares into Series A common stock and sold 200,000 shares in an open‑market transaction. The sale was reported as a weighted average price of $19.42 per share, for proceeds of approximately $3,884,000. The transactions were executed under a Rule 10b5‑1 trading plan.
Key Details
- Transaction date: 2026-03-31; Form 4 filed 2026-04-02 (timely filing).
- Sale: 200,000 shares sold in multiple trades at a weighted average price of $19.42; prices ranged from $18.85 to $19.75 per share (total ≈ $3,884,000). (Footnote F3: breakdown by price available on request.)
- Conversions: Reporting shows conversions of derivative securities (Series B → Series A) in connection with the transactions (see Footnote F2: Series B converts 1:1 into Series A and has no expiration).
- 10b5‑1 plan: Transactions effected pursuant to a plan adopted May 20, 2025 (Footnote F1).
- Trust holdings: Some shares are held in various Bialecki family trusts; the reporting person disclaims beneficial ownership of those shares except to the extent of any pecuniary interest (Footnotes F4–F6).
- Shares owned after the transaction: Not specified in the excerpt of the filing provided.
Context
- These were sales, not purchases—sales are commonly routine (e.g., planned disposals or tax/liquidity events) and do not necessarily indicate a change in the insider’s view of the company.
- The derivative conversions reflected are simply the corporate mechanism converting Series B common stock into Series A common stock (1:1 conversion per certificate of incorporation), enabling the open‑market sale.
Insider Transaction Report
Form 4
Klaviyo, Inc.KVYO
Bialecki Andrew
DirectorCo-Chief Executive Officer10% Owner
Transactions
- Conversion
Series A Common Stock
[F1][F2]2026-03-31+200,000→ 200,000 total - Sale
Series A Common Stock
[F1][F3]2026-03-31$19.42/sh−200,000$3,884,000→ 0 total - Conversion
Series B Common Stock
[F2][F1]2026-03-31−200,000→ 67,744,118 total→ Series A Common Stock (200,000 underlying)
Holdings
- 7,517,410(indirect: By Trust)
Series B Common Stock
[F2][F4]→ Series A Common Stock (7,517,410 underlying) - 517,006(indirect: By Trust)
Series B Common Stock
[F2][F5]→ Series A Common Stock (517,006 underlying) - 517,006(indirect: By Trust)
Series B Common Stock
[F2][F6]→ Series A Common Stock (517,006 underlying) - 43,218(indirect: By Spouse)
Series B Common Stock
[F2]→ Series A Common Stock (43,218 underlying)
Footnotes (6)
- [F1]These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2025.
- [F2]Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.85 to $19.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Shares held by the Andrew P. Bialecki Grantor Retained Annuity Trust I of 2023, of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
- [F5]Shares held by the Elizabeth L. Bialecki Irrevocable GST Trust of 2023, of which the Reporting Person serves as a trustee. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
- [F6]Shares held by the Andrew P. Bialecki Irrevocable GST Trust of 2023, of which the Reporting Person's spouse serves as a trustee. The Reporting Person disclaims Section 16 beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
Signature
/s/ Landon Edmond, Attorney-in-Fact|2026-04-02